Crinetics Pharmaceuticals Inc - CRNX - stock price prediction, stock price target, analyst ratings from 17 analysts

Crinetics Pharmaceuticals Inc has a share price target of US$ 69, revenue growth forecast of 452.9%, and profit growth estimate of -51.0% for FY25, based on top 17 analyst calls.